Camlin Fine Sciences Limited (IN:CAMLINFINE)
:CAMLINFINE
CAMLINFINE Stock Chart & Stats
₹144.30
-₹3.37(-2.50%)
At close: 4:00 PM EST
₹144.30
-₹3.37(-2.50%)
Day’s Range― - ―
52-Week Range₹96.30 - ₹334.70
Previous CloseN/A
Volume719.11K
Average Volume (3M)39.05K
Market Cap
₹21.04B
Enterprise Value₹26.86B
Total Cash (Recent Filing)₹1.63B
Total Debt (Recent Filing)₹6.72B
Price to Earnings (P/E)―
Beta0.86
Next Earnings
May 22, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding192,091,610
10 Day Avg. Volume26,894
30 Day Avg. Volume39,045
Financial Highlights & Ratios
PEG Ratio-0.48
Price to Book (P/B)3.33
Price to Sales (P/S)1.80
P/FCF Ratio-190.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹170.00Price Target Upside17.81% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)12.55
Revenue Forecast (FY)₹22.40B
Bulls Say, Bears Say
Bulls Say
B2B Specialty Chemicals ModelA focused B2B specialty-chemicals model serving food, beverage and industrial customers creates durable, repeatable demand. Ingredients like antioxidants and shelf-life solutions are embedded in customers' formulations, supporting long-term contractual sales and higher switching costs if quality/regulatory standards are met.
Moderate Leverage, Solid Equity RatioA moderate debt-to-equity ratio and a ~44.5% equity ratio provide balance-sheet resilience. This asset coverage reduces downside risk, supports working-capital needs and gives the company room to access financing for capex or growth initiatives without being over-levered during cyclical pressures in specialty chemicals.
Positive Revenue Growth TrendModest but positive revenue growth indicates underlying demand resilience for the company’s ingredient portfolio. In a B2B specialty market, steady top-line expansion provides a base to leverage fixed costs and eventually improve operating leverage if margins recover and utilization rises.
Bears Say
Negative Profitability / Net LossesSustained net losses and a negative net margin erode retained earnings and limit the firm’s ability to self-fund growth or return capital. Persistent unprofitability reduces resilience to raw-material swings and pricing pressure in specialty chemicals, making long-term recovery dependent on structural margin improvements.
Weak Cash Generation / Negative FCFDeclining operating cash flow and negative free cash flow constrain the company’s ability to fund maintenance capex, invest in product development, or reduce debt. For a manufacturing-intensive specialty-chemicals firm, prolonged weak cash generation raises refinancing risk and limits strategic flexibility.
Negative Return On EquityA negative ROE signals the business is not generating adequate returns on shareholders' capital. This undermines long-term investor confidence and indicates capital is currently unproductive; without sustained profit recovery, the company may struggle to attract funding for growth or modernization.
Camlin Fine Sciences Limited News
CAMLINFINE FAQ
What was Camlin Fine Sciences Limited’s price range in the past 12 months?
Camlin Fine Sciences Limited lowest stock price was ₹96.30 and its highest was ₹334.70 in the past 12 months.
What is Camlin Fine Sciences Limited’s market cap?
Camlin Fine Sciences Limited’s market cap is ₹21.04B.
When is Camlin Fine Sciences Limited’s upcoming earnings report date?
Camlin Fine Sciences Limited’s upcoming earnings report date is May 22, 2026 which is in 43 days.
How were Camlin Fine Sciences Limited’s earnings last quarter?
Camlin Fine Sciences Limited released its earnings results on Feb 13, 2026. The company reported -₹0.25 earnings per share for the quarter, missing the consensus estimate of ₹0.6 by -₹0.85.
Is Camlin Fine Sciences Limited overvalued?
According to Wall Street analysts Camlin Fine Sciences Limited’s price is currently Undervalued.
Does Camlin Fine Sciences Limited pay dividends?
Camlin Fine Sciences Limited pays a Annually dividend of ₹0.45 which represents an annual dividend yield of N/A. See more information on Camlin Fine Sciences Limited dividends here
What is Camlin Fine Sciences Limited’s EPS estimate?
Camlin Fine Sciences Limited’s EPS estimate is 0.1.
How many shares outstanding does Camlin Fine Sciences Limited have?
Camlin Fine Sciences Limited has 192,091,610 shares outstanding.
What happened to Camlin Fine Sciences Limited’s price movement after its last earnings report?
Camlin Fine Sciences Limited reported an EPS of -₹0.25 in its last earnings report, missing expectations of ₹0.6. Following the earnings report the stock price went down -2.633%.
Which hedge fund is a major shareholder of Camlin Fine Sciences Limited?
Currently, no hedge funds are holding shares in IN:CAMLINFINE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate; and mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters, as well as natural antioxidants, such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin; and nutraceutical products from fermentation and plant extraction sources. In addition, it offers performance chemicals, such as hydroquinone and catechol; and downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, HQEE, etc. The company also exports its products. Its products are used in food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemical, agrochemical, pharmaceutical, polymers, dyes and pigment, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplement industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
CAMLINFINE Stock 12 Month Forecast
Average Price Target
₹170.00
▲(17.81% Upside)
Technical Analysis
Advanced Enzyme Technologies Ltd
―
Balaji Amines Limited
―
Neogen Chemicals Ltd.
―
Premier Explosives Limited
―
Rossari Biotech Ltd
―